Biomarkers and Precision Medicine Community (BPMC)

 View Only
Back to discussions
Expand all | Collapse all

OSD on Feb 7th: Characterizing CD4 T Cell Immune Responses (Part 1)

  • 1.  OSD on Feb 7th: Characterizing CD4 T Cell Immune Responses (Part 1)

    Community Leadership
    Posted 01-08-2024 09:43

    Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Therapeutic Product Immunogenicity (TPI) and Biomarkers and Precision Medicine (BPM) Communities on February 7th, 12 - 1 pm ET on the following topic:

    Characterizing CD4 T Cell Immune Responses (Part 1)

    ·       Why is studying CD4 T cell responses important during preclinical immunogenicity risk assessment?

    ·       What are the features and challenges of different CD4 T cell assays?

    ·       How to choose and implement a CD4 T cell assay that is fit-for-purpose?

    Discussion Leaders:

    Jochem Gokemeijer (BMS), Bernard Maillere (CEA), Sophie Tourdot (Pfizer), and Laurent Malherbe (Lilly)

    Organized by:  Yi Wen (Lilly), Vibha Jawa (BMS), Carmen Fernández-Metzler (PharmaCadence) and Karen Quadrini (Prothena Biosciences)

    Note: Characterizing CD4 T Cell Immune Responses (Part 2) will occur on February 21st, 12 - 1 pm ET featuring regulatory perspectives, relevance, and inclusion of other assays for holistic immunogenicity risk assessment  

     

    We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

    (Please remain on mute unless asking questions)

     

    When: Wed, Feb 7, 2024, 12 pm – 1 pm ET

    Where: Please join from your computer, tablet or smartphone.
    https://global.gotomeeting.com/join/305789893

    You can also dial in using your phone.
    United States:     +1 (872) 240-3412
    Access Code: 305-789-893

    Join from a video-conferencing room or system.
    Dial in or type:     67.217.95.2 or inroomlink.goto.com
    Meeting ID: 305 789 893
    Or dial directly:     [email protected] or 67.217.95.2##305789893

    New to GoToMeeting? Get the app now and be ready when your first meeting starts:
    https://global.gotomeeting.com/install/305789893

     

    Please feel free to share with colleagues who may be interested in this topic.

     

    Thank you,

    The Leadership Teams of the AAPS TPI and BPM Communities

    #OpenScientificDiscussions  #OSD  #biomarker  #Immunogenicity  #immunity



    ------------------------------
    Karen Quadrini, PhD
    Director, Biomarkers and Precision Medicine
    Passage Bio
    Philadelphia, PA
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------